Trends in use of warfarin and direct oral anticoagulants in atrial fibrillation in Norway, 2010 to 2015.
Lars Jøran KjerpesethHanne EllekjærRandi SelmerInger AriansenKari FuruEva SkovlundPublished in: European journal of clinical pharmacology (2017)
Use of DOACs for anticoagulation in atrial fibrillation became more prevalent between 2010 and 2015 in Norway, at the expense of warfarin.